Phase 2 Recurrent Colorectal Cancer Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 1Phase 2

Nelmastobart in Combination With Trifluridine/ Tipiracil and Bevacizumab in Metastatic/ Recurrent Colorectal Cancer

Metastatic Colorectal Cancer (CRC)Recurrent Colorectal Cancer

STCube, Inc.52 enrolled5 locationsNCT06873763

Recruiting

Phase 2

CapeOX Combined With Bevacizumab Plus Anti-PD1 Antibody as Neoadjuvant Therapy for Locally Recurrent Colorectal Cancer

Locally Recurrent Colorectal Cancer

Shanghai Changzheng Hospital15 enrolled1 locationNCT06881537